| Product dosage: 2mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.01 | $40.14 (0%) | 🛒 Add to cart |
| 20 | $2.51 | $80.27 $50.17 (38%) | 🛒 Add to cart |
| 30 | $2.01 | $120.41 $60.21 (50%) | 🛒 Add to cart |
| 60 | $1.34 | $240.82 $80.27 (67%) | 🛒 Add to cart |
| 90 | $1.23 | $361.23 $110.38 (69%) | 🛒 Add to cart |
| 120 | $1.17 | $481.64 $140.48 (71%) | 🛒 Add to cart |
| 180 | $0.89 | $722.46 $160.55 (78%) | 🛒 Add to cart |
| 270 | $0.82 | $1083.69 $220.75 (80%) | 🛒 Add to cart |
| 360 | $0.79
Best per pill | $1444.92 $285.97 (80%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
zanaflex
Tizanidine hydrochloride - that’s the generic name we’re discussing here, though most people know it as Zanaflex. It’s one of those medications that sits in that interesting space between muscle relaxants and central alpha-2 adrenergic agonists. What’s fascinating about tizanidine is how it evolved from being just another potential antihypertensive to becoming a first-line choice for spasticity management. The story actually begins in the 1980s when researchers at Sandoz were investigating novel compounds for blood pressure control, and they stumbled upon this unique agent that showed remarkable muscle-relaxing properties without the significant cardiovascular effects they’d anticipated.
lioresal
Baclofen, marketed under the brand name Lioresal among others, is a medication primarily used to treat spasticity. It is a central nervous system (CNS) depressant and acts as a GABAB receptor agonist. This agent represents a cornerstone in the management of muscle spasticity resulting from conditions such as multiple sclerosis, spinal cord injuries, and cerebral palsy. Unlike peripheral muscle relaxants, baclofen exerts its effects directly within the spinal cord and brain, modulating neurotransmitter release to reduce excessive muscle tone and spasms.
skelaxin
Metaxalone, a centrally acting skeletal muscle relaxant, has been part of our musculoskeletal toolkit for decades. It’s one of those older drugs that doesn’t get the flashy new studies but has persisted in formularies because, in the right patient, it just works with a relatively favorable side effect profile compared to some alternatives. It’s not a benzodiazepine derivative, which is a key point, and its exact mechanism has been a topic of discussion—we’ll get into that.
abana
Product Description Abana represents one of those formulations that initially puzzled me when I first encountered it in practice - a comprehensive herbal supplement with roots in Ayurvedic medicine, primarily indicated for cardiovascular support. What struck me during my early years at the Cleveland Clinic was how this multi-herb preparation kept appearing in patients’ medication lists, particularly among those with familial hyperlipidemia patterns. The formulation contains a sophisticated blend of Terminalia arjuna, Inula racemosa, Commiphora mukul, and several other botanicals that work synergistically - something we rarely see in single-component pharmaceuticals.
abhigra
Product Description: Abhigra represents a novel class of medical-grade nutraceutical devices that combines standardized botanical extracts with a patented sublingual delivery system. Unlike conventional supplements, its mechanism relies on transmucosal absorption bypassing first-pass metabolism, which we’ve observed yields significantly faster onset of action—particularly valuable for acute inflammatory episodes. The development team spent three years battling stability issues with the nanoemulsion matrix before discovering that alternating temperature cycles during production actually enhanced bioactive preservation, contrary to our initial assumptions.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in psychopharmacology as a second-generation antipsychotic medication. Unlike first-generation antipsychotics that primarily function as dopamine D2 receptor antagonists, aripiprazole exhibits a unique mechanism as a partial dopamine agonist. This pharmacological profile allows it to stabilize dopamine activity rather than simply blocking it, creating what many clinicians describe as a “dopamine stabilizer” effect. The medication has received FDA approval for multiple psychiatric conditions including schizophrenia, bipolar disorder, major depressive disorder (as adjunct treatment), Tourette’s disorder, and irritability associated with autistic disorder.
Acamprol: Targeted Neurological Support for Hyperexcitability Disorders - Evidence-Based Review
In my early neurology practice, we kept hitting walls with certain patients—the ones with persistent neurological irritability where standard GABAergics either failed or caused unacceptable sedation. That’s when our hospital’s pharmacology team first showed me the molecular structure of what would become Acamprol. It wasn’t another benzodiazepine analog or some exotic plant extract, but a synthetic compound mimicking taurine’s neuromodulatory properties. We initially called it “Calcium Acetylhomotaurinate” until the brand name stuck.
Accufine: Advanced Continuous Glucose Monitoring for Diabetes Management - Evidence-Based Review
Product Description: Accufine represents a significant advancement in non-invasive glucose monitoring technology. It’s a continuous glucose monitoring (CGM) system that uses micro-needle sensor technology combined with advanced algorithms to provide real-time interstitial fluid glucose readings without the traditional fingerstick calibration. The device consists of a discreet wearable sensor that transmits data to both a dedicated reader and compatible smartphone applications, allowing for comprehensive glucose trend analysis and predictive alerts. I remember when we first started developing this technology back in 2018 - our team was divided between pursuing traditional electrochemical sensing versus this novel optical approach.
Accupril: Effective Blood Pressure Control and Heart Failure Management - Evidence-Based Review
Accupril, known generically as quinapril hydrochloride, represents a significant advancement in the angiotensin-converting enzyme (ACE) inhibitor class, primarily prescribed for managing hypertension and heart failure. This comprehensive monograph examines its pharmacological profile, clinical applications, and practical considerations based on current evidence and extensive clinical experience. 1. Introduction: What is Accupril? Its Role in Modern Medicine Accupril belongs to the angiotensin-converting enzyme (ACE) inhibitor class of cardiovascular medications. What is Accupril used for?